November 19, 2020
Animine launches zinc oxide research programme
Independent French supplier of trace minerals Animine has launched its ZinCoSupp® R&D project. ZinCoSupp stands for both SUPPression of pharmacological ZnO, and SUPPlementation of the right zinc oxide source at the right dosage.
Medicated zinc oxide plays a huge role in animal husbandry to prevent post-weaning diarrhoea. However, stricter regulations in Europe and around the world mean the feed additives industry is stepping up research efforts in this area. The ban of zinc oxide in the European Union is restricted to medicated feeds which are prescribed by veterinarians. This does not apply to the nutritional usage of zinc oxide which remains the dominant source of zinc utilised by the feed industry.
The ZinCoSupp project brings together several well-recognised universities from western Europe (Berlin, Bologna, Leeds, Milan, Kiel & Ghent). Under the guidance of reputed scientists, these universities will drive several PhD thesis projects for Animine. In addition, a complementary PhD thesis project led by the University of Hohenheim and with contribution from the University of Georgia (US) will study HiZox® with a particular focus on the interaction among dietary zinc and phytase efficacy on phosphorus release from phytic acid. The main goal of this large-scale R&D programme is to offer solutions to the upcoming regulatory challenge in the EU by highlighting benefits of zinc from a potentiated source HiZox on gut morphology, function and health versus other zinc sources available.
Animine believes the findings will be valuable for today and tomorrow's swine production systems globally. It will help to prepare strategic plans for a shift towards more sustainable production systems while limiting the occurrence of digestive disorders around weaning, and maintaining high productivity levels.
Animine is hosting a public webinar on December 15 (9am CET, 3pm Thailand time) to reveal the content of the R&D project in the presence of Prof. Zentec, Prof. Trevisi and Dr Taylor. For more information, please contact: email@example.com